KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Exchange Rate Effect (2017 - 2025)

Historic Exchange Rate Effect for Teladoc Health (TDOC) over the last 9 years, with Q3 2025 value amounting to -$324000.0.

  • Teladoc Health's Exchange Rate Effect fell 11843.0% to -$324000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 114.94%. This contributed to the annual value of -$3.3 million for FY2024, which is 44072.54% down from last year.
  • Per Teladoc Health's latest filing, its Exchange Rate Effect stood at -$324000.0 for Q3 2025, which was down 11843.0% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Exchange Rate Effect registered a high of $4.5 million during Q2 2025, and its lowest value of -$3.9 million during Q4 2024.
  • Its 5-year average for Exchange Rate Effect is -$90526.3, with a median of -$324000.0 in 2025.
  • In the last 5 years, Teladoc Health's Exchange Rate Effect surged by 246981.13% in 2022 and then crashed by 38619.15% in 2024.
  • Teladoc Health's Exchange Rate Effect (Quarter) stood at -$106000.0 in 2021, then soared by 2469.81% to $2.5 million in 2022, then plummeted by 46.38% to $1.3 million in 2023, then tumbled by 386.19% to -$3.9 million in 2024, then surged by 91.6% to -$324000.0 in 2025.
  • Its last three reported values are -$324000.0 in Q3 2025, $4.5 million for Q2 2025, and $1.6 million during Q1 2025.